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Relative to their normal counterparts, tumor cells generally exhibit a greater “stress phenotype” and express heat shock proteins
(Hsp) that represent candidate targets for anticancer therapy. Here we investigated the role of Hsp70 in survival induced by
endoplasmic reticulum (ER) stressors in human leukemia U937 cells. Quercetin, a major dietary +avonoid, or speci,c silencing
a-ected the expression level of Hsp70 and did not allow the upregulation of inositol-requiring kinase 1훼 (IRE1훼), the prototype
ER stress sensor regulating the unfolded protein response (UPR), that protects the cells against the stress of misfolded proteins
in the ER. (e reduction of Hsp70 prevented the upregulation of immunoglobulin heavy-chain binding protein (BiP), but not
of CCAAT/enhancer-binding protein-homologous protein (CHOP), and induced apoptosis. Also speci,c silencing of IRE1훼 or
inhibition of its endoribonuclease activity by 4휇8c hampered the upregulation of BiP, but not of CHOP, and induced apoptosis.
(ese results suggest that drugs a-ecting theHsp70-IRE1훼 axis, like quercetin, or a-ecting directly IRE1훼may represent an e-ective
adjuvant antileukemia therapy.
1. Introduction
Disturbances in ER calcium homeostasis or protein process-
ing cause the accumulation ofmisfolded or unfolded proteins
in the ER, a cellular condition referred to as “ER stress.”
Adaptation to ER stress is mediated by the induction of the
unfolded protein response (UPR), a regulated and complex
signal transduction pathway transmitting information to the
cytosol and nucleus to increase protein folding capacity of the
ER [1–3]. However, cells undergo apoptosis when adaptation
mechanisms are unable to alleviate the ER stress [4, 5].(us,
the UPR serves to mitigate the stress or, alternatively, to
eliminate stressed cells in order to protect the organism.
(e hallmark of the UPR is the upregulation of ER
chaperones and folding enzymes, which are required to bind
the unfolded proteins and prevent their aggregation [6]. Also
a transient attenuation of protein synthesis participates to the
UPR by limiting the load of proteins under conditions not
well suited to their proper folding [7].
(ree resident ER transmembrane sensors detect unfold-
ed proteins in the ER to initiate three distinct UPR branches:
inositol-requiring kinase-1훼 (IRE1훼), activating transcription
factor-6 (ATF6), and protein kinase RNA- (PKR-) like ER
kinase (PERK) [3, 6–8]. All these sensors have luminal
domains that bind BiP under nonstress conditions. Once the
ER stress leads to accumulation of unfolded proteins, BiP is
released from theUPR sensors and binds to the unfolded pro-
teins.(ese events trigger the activation of the ER sensors [9,
10]. IRE1훼 is evolutionarily conserved from yeast to humans;
it is a Ser/(r protein kinase and endoribonuclease that, upon
activation, initiates the splicing of the mRNA encoding X-
box binding protein 1 (XBP-1), converting it into a highly
active transcription factor, termed XBP-1s. (is is a key
regulator of ER folding capacity that upregulates important
genes related to control of protein quality, ER translocation,
glycosylation, and ER/Golgi biogenesis [11, 12]. XBP-1s regu-
lates several UPR target genes including ER chaperones like
BiP, transcription factors like CHOP, and other proteins [13].
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BiP plays an antiapoptotic and cytoprotective role in early
embryogenesis, oncogenesis, neurodegenerative diseases,
and atherosclerosis [13, 14], while CHOP has been linked
to apoptosis [15, 16]. CHOP downregulates antiapoptotic
proteins like Bcl2 and increases free oxygen species, causing
mitochondrial membrane damage and cytochromeC release.
Heat shock proteins (Hsp), classi,ed according to their
approximate molecular size, comprise several members
exhibiting di-erent expression patterns or expressed in dif-
ferent cell compartments. (e Hsp70 family has more than
8 members. It includes the major cytoplasmic forms called
heat shock cognate (Hsc) 70, Hsp73, HspA8, Hsp70, themito-
chondrial protein GRP75, and the endoplasmic reticulum-
resident GRP78. Hsc70 is constitutively and ubiquitously
expressed. Hsp70, also named Hsp72, is generally expressed
at very low or undetectable levels in unstressed normal
cells while it is highly expressed in many malignant tumors,
consistent with the idea that it represents a prosurvival factor,
playing an essential role as chaperone in protein folding [17–
19]. Overexpressed Hsp72 can bind to IRE1훼 and enhance its
RNase activity, promoting adaptation to ER stress and cell
survival [20]. A role of Hsp70 in tumorigenesis has been sug-
gested, based on the fact that its overexpression in transgenic
mice results in T-cell lymphoma [21].(e high expression of
Hsp70 in tumor cells increases the resistance to apoptosis and
has been associated with poor prognosis of cancer patients
[22–25]. An altered expression or function of Hsp70 has been
implicated in other human diseases, associated with defects
in protein conformation or folding, as disorders caused by
mutant proteins or some neurodegenerative diseases, such
as Alzheimer’s disease and Parkinson’s disease [26, 27].
Furthermore, it is known that Hsp70 downregulation results
in apoptosis in cancer cells but not in untransformed cells,
which makes this protein an attractive target for molecular
cancer therapeutics and chemoprevention.
In the present studies we set out to investigate the role
of Hsp70, constitutively expressed in human monoblastic
leukemia U937 cells, in the regulation of the UPR induced
by the ER stressors tunicamycin (TN) and thapsigargin (TG).
TN inhibits N-linked glycosylation resulting in accumulation
of misfolded proteins, whereas TG inhibits Ca++ uptake by
the ER, both resulting in ER stress induction. Hsp70 was
silenced or its expression was reduced by quercetin (Q) [28],
a major dietary +avonoid, that is going to be evaluated in a
cancer clinical trial, based on its antiproliferative and anti-
tyrosine kinase activities [29].
(e present studies demonstrate a functional link
betweenHsp70 and IRE1훼: targetingHsp70withQor speci,c
silencing, while not modifying CHOP upregulation, did
not allow the upregulation of IRE1훼 and BiP following ER
stress and promoted cell death. (ese results indicate that
quercetin, in combination with drugs causing endoplasmic
reticulum stress, may represent an e-ective adjuvant antileu-
kemia therapy.
2. Materials and Methods
2.1. Materials. Antibody anti-훽-actin, BSA, FCS, HBSS, l-
glutamine, penicillin-streptomycin, PBS, propidium iodide
(PI), Q, RNAse, RPMI-1640, and tunicamycin were from
Sigma-Aldrich (St. Louis, MO, USA). Antibodies anti-BiP,
-caspase 3, -CHOP, -Hsp70, -Hsp90, -IRE1훼, and -PARP
were from Cell Signaling Technology (Beverly, MA, USA).
Horseradish peroxidase- (HRP-) conjugated anti-rabbit- and
anti-mouse-immunoglobulin antibodies, enhanced chemi-
luminescence (ECL) reagents, and Hyper,lm-ECL ,lm
were from Amersham (Arlington Heights, IL, USA). Lipo-
fectamine RNAiMAX and OPTI-MEM medium, small
interfering- (siRNA-) IRE1, and relative scrambled siRNA
(Ambion) were from Life Technologies (Invitrogen, San
Giuliano Milanese, Italy). 2-Phenylethynesulfonamide (PES)
and 4휇8c were from Merck (INALCO, Milan, Italy). RC-
DC protein assay, SDS-sample bu-er, protein standard,
SDS-PAGE reagents, and polyvinylidene di+uoride (PVDF)
membranes were from Bio-Rad Laboratories (Segrate, Italy).
Antibody anti-tubulin, siRNA-Hsp70, and scrambled siRNA
were purchased from Santa Cruz Biotechnology (Tebu-Bio,
Magenta, Italy). (apsigargin and z-VAD.fmk were from
Calbiochem (San Diego, CA, USA). Other reagents were of
the highest purity and purchased from Bio-Rad, Invitrogen,
or Sigma.
2.2. Cell Viability and Growth. (e human monoblastic
leukemia cell line U937, derived from a patient with dif-
fuse histiocytic lymphoma, was used. Cells were grown in
complete medium (RPMI-1640 medium supplemented with
5% heat-inactivated FCS, 2mM glutamine, 100 units/mL
penicillin, and 100 휇g/mL streptomycin) at 37∘C, in fully
humidi,ed 95% room air/5% CO2. Cells were resuspended
three times a week in fresh complete medium to 3 × 105/mL.
Cell growth was evaluated by hemocytometry counts of cells
excluding trypan blue (0.04% Trypan blue in PBS, w/v),
and viability was assessed by calculating alive (trypan blue
excluding) cells as percentage of all cells counted (trypan blue
excluding and not excluding). Cells used in every experiment
were ≥94% viable and taken from cultures in exponential
growth.(eywerewashed once and resuspended in complete
medium, 1× 106/mL, and transferred tomultiwell plates.(ey
were then treated with inhibitors or vehicles, incubated for
30min, and subsequently exposed to test agents or, again,
to vehicles. At the end of each experiment, the cells were
gently mixed and aliquots were taken for cell counting, PI
staining, and cell cycle analysis.(e vehicles, even when used
in combination, were ≤0.3% (v/v) and did not modify any
investigated parameter in comparison with control cultures.
2.3. Flow Cytometry Analysis of Cell Death. Nuclear DNA
fragmentation was quanti,ed by +ow cytometry of hypodip-
loic (subG1) DNA a/er cell ,xation and PI staining [30, 31].
Brie+y, cells were washed with PBS, pelleted and ,xed in
ice cold ethanol/water (70/30, v/v) for 1 h, pelleted again
and washed twice with PBS, and ,nally resuspended in PBS
containing RNAse (20 휇g/mL) and PI (100 휇g/mL). Events
in the di-erent cell cycle phases were gated manually using
an EPICS XL cyto+uorimeter (Beckman Coulter, Hialeah, Fl,
USA). At least 10.000 events/sample were acquired. Collected
data were analyzed using the Multicycle so/ware for DNA
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content and cell cycle analysis (Phoenix Flow System, San
Diego, CA, USA). (e subG1 events representative of the
apoptotic cells, and the events in the other cell cycle phases,
are given as percentage of the total cell population.
Membrane permeability, indicative of cell death, was
investigated by resuspending the cells in HBSS containing
PI (200휇g/mL) at room temperature and analyzed by +ow
cytometry (EPICS-XL), measuring the +uorescence emission
at >575 nm (FL3).
2.4. Western Blot Analysis. Whole cell lysates were prepared
as previously described [32]. Brie+y, the cells were kept for
30min on ice in lysis bu-er (NaCl 150mM, CaCl2 1mM,
MgCl2 1mM, NaN3 0.1%, NaF 10mM, Triton X-100 1%
(v/v), orthovanadate 1mM, aprotinin 2 휇g/mL, leupeptin
2 휇g/mL, iodoacetamide 10mM, PMSF 2mM, and pepstatin
20휇M). (e appropriate volumes of 4x SDS-sample bu-er
(v/v) were then added. Cell lysates were brie+y sonicated,
warmed at 95∘C for 5min, and cleared by 14000×g cen-
trifugation in a microfuge for 15min at 4∘C. Supernatants
were collected and proteins were quanti,ed by RC DC
protein assay. Equal amounts of proteins were separated
from the di-erent samples by SDS-PAGE, and blotted onto
PVDF membranes. Transfer e0ciency was checked with
Ponceau staining. (e blots were blocked in tris-bu-ered
saline (TBS) containing BSA 5% (w/v), probed with speci,c
primary antibodies (anti-BiP, -CHOP, -Hsp70, -IRE1훼, or
-PARP), washedwith PBS-Tween 20, and then incubatedwith
the appropriate peroxidase-conjugated secondary antibody.
Finally, in order to control protein loading, each membrane
was probed to detect훽-actin, tubulin,Hsp90, or caspase 3 and
the appropriate peroxidase-conjugated secondary antibody.
For each antibody were used the dilutions and incubation
times suggested by the manufacturer. Immunodetection was
performed using the ECL reagents and Hyper,lm-ECL ,lm.
Densitometry quantitation of the bands was performed using
ImageJ so/ware (National Institutes of Health, Bethesda,
MD, USA) on a Mac OS X (Apple Computer International,
Cupertino, CA, USA).
2.5. siRNA. RNA knockdown was performed with pools of
siRNA duplexes. Brie+y, cells were washed and resuspended
in OPTI-MEM medium, transfected with siRNA speci,c
for human Hsp70 and scrambled siRNA (Santa-Cruz) or
with siRNA speci,c for IRE1훼 and relative scrambled siRNA
(Ambion), using Lipofectamine RNAiMAX according to the
manufacturer’s guidelines and as we previously described
[33]. A/er 12 h of incubation, RPMI 1640 containing 20%
fetal calf serumwas added without removing the transfection
medium. (e cells were cultured for further 60 h. A/er
centrifugation, the medium was replaced with fresh RPMI-
1640, containing 10% fetal calf serum, and the cells cultured
again in the presence or not of TN.
2.6. Statistical Analysis. Results are expressed as the mean ±
standard deviation (SD) of repeated experiments, as indicated
in the ,gure legends. Statistical di-erences between the data
sets were evaluated using unpaired, two-tailed Student’s 푡-
test. Values of 푃 < 0.05 were considered statistically signif-
icant.
3. Results
3.1. Survival of U937 Cells under Moderate ER Stress Con-
ditions. TN and TG are ER stressors that induce U937 cell
death in a dose-dependent manner and that activate a pro-
survival pathway at low concentrations [33]. In particular, TN
(1 휇M) caused a moderate increase of PI incorporating (PI+)
cells (18±7%) in comparisonwith untreated cultures (6±1%)
(Figure 1(a)), in addition to the appearance of 19±6% of sub-
G1 events (Figure 1(b)). Similarly, TG (200 nM) caused a fall
in cell viability (PI+ cells 23 ± 5%) (Figure 1(a)) and induced
the appearance of sub-G1 events (24 ± 7%) (Figure 1(b)).
Sub-G1 events were studied by cyto+uorimetry of cell cycle
phases of cells ,xed and stained with PI. (e hypodiploid
DNA events were easily discernible from the narrow peak
of cells with diploid DNA content; they are considered
to be indicative of apoptotic nuclei [30, 33]. Furthermore,
analysis of events in the di-erent cell cycle phases showed
that TN (1 휇M) and TG (200 nM) caused a decrease in S
and G2M phases, while the percentage of G1 events were
apparently unchanged (Figure 1(c)). Cell counts indicated
that neither TN nor TG allowed cell growth (not shown).
(ese results show that these ER stressors, at the indicated
low concentrations, cause activation of a prosurvival pathway
in U937 cells, arrested in G1 cell cycle phase. To investigate
this prosurvival pathway, all the experiments were performed
with TN 1 휇M and TG 200 nM, and viability parameters were
investigated a/er 24 h.
3.2. Quercetin Downregulates the Expression of Hsp70 in U937
Cells. Hsp70 is present at constitutively high levels in various
human tumors, in contrast to its low expression in unstressed
normal cells. It is an important chaperone that plays a
key role in conformational maturation and stabilization of
proteins involved in cell growth and survival. Also U937
tumor cells express constitutively rather high levels of Hsp70,
not apparently modi,ed by the ER stress induced by TN
or TG (Figure 2(a)). Q is known to inhibit the synthesis of
Hsp70 in some human cancer cell lines [28]. (is +avonoid,
at high doses, is cytotoxic and can block proliferation of U937
cells (unpublished results). (us, we used the concentration
10 휇M to avoid its cytotoxic e-ects. We found that quercetin
(30min, cell pretreatment) reduced the expression of Hsp70
in U937 cells under basal conditions as well as upon TN or
TG treatments (Figure 2(a)).
3.3. Hsp70 Protects ER Stressed Cells from Death. Q caused
per se a moderate increase of U937 cell death, as determined
by evaluation of PI+ cells (14 ± 4%) and sub-G1 events (13 ±3%) (Figures 2(b) and 2(c)). However, when combined with
TN or TG, it caused a conspicuous increase of PI+ cells
and sub-G1 events (Figures 2(b) and 2(c)). (us, Q turns
the survival induced by the ER stressors into cell death. PES
is a pharmacological inhibitor of Hsp70 [34, 35]. It (10 휇M,
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Figure 1: Low doses of the ER stressors, TN or TG, are not cytotoxic to U937 cells. U937 cells either exposed or not to TN 1 휇M or TG
200 nM for 24 h. (a) A cell portion was un,xed, stained with PI and immediately ≥10000 events were analyzed in a cyto+uorimeter in order to
evaluate the dead cells incorporating PI as percentage of total events. (b and c) A cell portion was ,xed and therea/er stained with PI in order
to evaluate by cyto+uorimetry, among ≥10000 events, those in sub-G1 (b) and in sub-G1, G1, S, and G2M (c) of the cell cycle.(e reported
values represent the means and error bars, the S.D. of dead cells (PI+), or sub-G1 events of 12 independent experiments. Assessment of cell
death showed statistically signi,cant di-erences between the data obtained in the cultures treated with TN or TG in comparison with the
untreated cultures (∗푃 < 0.0001).
30min cell pretreatment) was slightly cytotoxic for U937
cells (PI+ cells 14 ± 3%; sub-G1 events 10.7 ± 3%) and
more cytotoxic when associated with TN or TG (Figures
2(b) and 2(c)). In order to rule out o--target e-ects of the
pharmacological inhibitors, Hsp70 expression was silenced
by speci,c siRNA. A/er transfection time (72 h), TN was
added for the subsequent 24 h. In comparison with scr-
siRNA, Hsp70 speci,c silencing brought about an e-ective
reduction ofHsp70 (Figure 2(d)) and caused a strong increase
of cell death in ER stressed cells (Figure 2(e)).
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Figure 2: Hsp70 promotes survival of ER stressed cells. (a) Hsp70 was detected by western blot in the lysates of U937 cells either exposed
or not to Q (10 휇M, 30min) and therea/er to none or TN 1 휇M or TG 200 nM for 24 h. Blotted proteins were probed with anti-Hsp70
followed by peroxidase-conjugated secondary antibody. Western blot of 훽-actin is shown at the bottom as a loading control. Representative
blots are shown. Densitometric quanti,cation of the bands is shown at the bottom of the relevant lines as the ratio of Hsp70 in each line to
the Hsp70 value observed in the lysate of untreated U937 cells. (b and c) Detection of cell death by evaluation of PI+ cells (b) or of sub-G1
events (c). U937 cells were pretreated for 30min with none or Q (10 휇M) or PES (10휇M) and then with none or TN (1휇M) or TG (200 nM).
A portion of cells were un,xed and stained with PI (b) or ,xed and stained with PI to evaluate sub-G1 events in the cell cycle (c) under
cyto+uorimetry. Both types of investigation were performed on ≥10000 events. (e values reported are means ± S.D. (푛 = 6). Assessment
of cell death showed statistically signi,cant di-erences between the data obtained in the cultures treated with TN or TG together with Q
or with PES, in comparison with the cultures treated only with Q (∘푃 < 0.0001) or only with PES (∘∘푃 < 0.0001) or only with TN or TG
(∗푃 < 0.0001; ∗∗푃 < 0.003; ∗∗∗푃 < 0.03). (d) Western blot analysis of Hsp70 by speci,c antibody in the lysates of U937 cells transfected with
equal amounts of Hsp70 siRNA or scr-siRNA for 72 h and exposed to none or to TN 1휇M for further 24 h. Western blot analysis of 훽-actin
is shown at the bottom, as a loading control and also to con,rm the speci,city of the transfected siRNA. Representative blots are shown.
Densitometric quanti,cation of the bands is shown at the bottom of the relevant lines as the ratio of Hsp70 in each line to the Hsp70 value
observed in the lysate of untreated U937 cells transfected with scrambled siRNA. (e) U937 cells transfected with Hsp70 siRNA or scr-siRNA
for 72 h and exposed or not to TN 1 휇M for 24 h were ,xed with ethanol, stained with PI, and analyzed under cyto+uorimetry to detect sub-
G1 events in the cell cycle. Here are shown the mean ± S.D. of four independent experiments. Assessment of cell death showed statistically
signi,cant di-erences between the data obtained in the cultures treated with scr-siRNA and TN in comparison with the cultures treated only
with scr-siRNA (∗푃 < 0.005) or with Hsp70 siRNA and TN in comparison with scr-siRNA or Hsp70 siRNA (∗∗푃 = 0.001).
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Figure 3: IRE1훼 expression is linked toHsp70. (a)Western blot was performedwith anti-IRE1훼 followed by peroxidase-conjugated secondary
antibody to analyze this ER sensor in the lysates of untreated (0 h) or TN treated U937 cells for the hours indicated. Western blot of 훽-actin is
shown at the bottom as a loading control. Representative blots are shown. Densitometric quanti,cation of the bands is shown at the bottom
of the relevant lines as the ratio of IRE1훼 in each line to the IRE1훼 value observed in the lysate of untreated U937 cells. (b) Western blot was
performed with anti-IRE1훼 followed by peroxidase-conjugated secondary antibody to analyze this ER sensor in the lysates of untreated cells
or Q (10휇M) or PES (10휇M) pretreated cells, therea/er treated with none or TN or TG for 24 h. Western blot of caspase 3 is shown at the
bottom as a loading control. Representative blots are shown. Densitometric quanti,cation of the bands is shown at the bottom of the relevant
lines as the ratio of IRE1훼 in each line to the IRE1훼 value observed in the lysate of untreated U937 cells. (c) Western blot analysis of IRE1훼 by
speci,c antibody in the lysates of U937 cells transfected with equal amounts of Hsp70 siRNA or scr-siRNA (Santa Cruz) for 72 h and exposed
to none or to TN 1휇M for further 24 h. Western blot analysis of 훽-actin is shown at the bottom, as a loading control and also to con,rm the
speci,city of the transfected siRNA. Representative blots are shown. Densitometric quanti,cation of the bands is shown at the bottom of the
relevant lines as the ratio of IRE1훼 in each line to the IRE1훼 value observed in the lysate of untreated U937 cells transfected with scrambled
siRNA.
(ese results show that Hsp70 promotes survival of ER
stressed cells.
3.4. Hsp70 and IRE1훼 Are Functionally Linked. Among the
three major transmembrane sensors of ER stress (IRE1훼,
PERK, and ATF6), IRE1훼 is the prototype ER stress sensor,
evolutionarily conserved from yeast to human.(e cytopro-
tective output of IRE1훼 is present across all eukaryotes. We
examined the expression level of this sensor in U937 cells
treated with TN and found that it was upregulated a/er 6 h,
even more a/er 12, 15, and 18 h, and it remained high a/er
24 h (Figure 3(a)). Similar results were obtained using TG, as
ER stressor (not shown).
In order to investigate the link betweenHsp70 and IRE1훼,
U937 cells were pretreated with Q or PES, as the former drug
a-ects Hsp70 expression, while the latter inhibits it. Both
pretreatments prevented the upregulation of IRE1훼 following
ER stress (Figure 3(b)). To rule out any unspeci,c e-ect of the
used inhibitors, IRE1훼 was analyzed by western blot in cells
silenced for Hsp70. In comparison with scr-siRNA, Hsp70
silencing e-ectively decreased the expression of constitutive
IRE1훼 and prevented the increased expression of this ER
sensor caused by TN treatment (Figure 3(c)).
(ese experiments indicate a functional link between
Hsp70 and IRE1훼.
3.5. Hsp70 Regulates BiP Expression through IRE1훼. A num-
ber of studies have shown that cell survival or death deci-
sions during the UPR are, respectively, mediated via the
antiapoptotic BiP or the proapoptotic CHOP. We therefore
examined the expression of these proteins by western blot in
ER stressedU937 cells. TN, as previously reported, resulted in
upregulation of BiP and CHOP, which became evident a/er
6 h and increased a/er 12 and 24 hof treatment [33]; quercetin
or speci,c silencing ofHsp70 did not in+uence the expression
ofCHOP,while they prevented substantially BiP upregulation
(Figures 4(a) and 4(b)).
IRE1훼 is a Ser/(r protein kinase and endoribonuclease
that, upon activation, initiates the unconventional splicing
of the X-box binding protein (XBP-1) mRNA. (e product
of this splicing is XBP-1s, a highly active transcription factor
and one of the key regulators of ER folding capacity. 4휇8c is
an inhibitor of IRE1훼 endoribonuclease activity [36]. IRE1훼
inhibition with 4휇8c (10 휇M, cell pretreatment 30min) or its
speci,c silencing prevented BiP, but not CHOP induction
a/er 24 h of TN treatment (Figures 4(a) and 4(b)). When
TG was used, similar results were observed (not shown).(e
inhibition of IRE1훼 by 4휇8c caused a slight increase of sub-G1
events, more evident a/er TN treatment (Figure 5(c)).
(ese results indicate that in U937 cells undergoing a
moderate ER stress Hsp70 promotes BiP upregulation
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Figure 4: Impairment of Hsp70 prevents upregulation of BiP but not of CHOP. (a) Western blot was performed with anti-BiP or anti-CHOP
followed by peroxidase-conjugated speci,c secondary antibody to analyze these proteins in the lysates of untreated cells or Q (10휇M) or 4휇8c
(10휇M) pretreated cells and therea/er treated with none or TN for 24 h. Western blot of Hsp90 is shown at the bottom as a loading control.
Representative blots are shown. Densitometric quanti,cation of the bands is shown at the bottom of the relevant lines as the ratio of BiP or
CHOP in each line, respectively, to the BiP or CHOP values observed in the lysate of untreated U937 cells or to the CHOP value observed in
TN treated cells. Western blot analysis of Hsp90 is shown at the bottom, as a loading control. (b) Western blot analysis of BiP or CHOP by
speci,c antibody in the lysates of U937 cells transfected with equal amounts of Hsp70 siRNA or scr-siRNA (Santa Cruz) or equal amounts of
IRE1훼 siRNA or scr-siRNA (Ambion) for 72 h and exposed to none or to TN 1휇M for further 24 h. Western blot analysis of 훽-actin is shown
at the bottom, as a loading control and also to con,rm the speci,city of the transfected siRNA. Representative blots are shown. Densitometric
quanti,cation of the bands is shown at the bottom of the relevant lines as the ratio of BiP or CHOP in each line, respectively, to the BiP or
CHOP values observed in the lysate of untreated U937 cells transfected with scrambled siRNA (Santa Cruz). (c) Detection of cell death by
evaluation of sub-G1 events. U937 cells were pretreated for 30min with none or 4휇8c (10휇M) and therea/er for 24 h with none or TN (1 휇M).
(e cells were ,xed and stained with PI to evaluate sub-G1 events in the cell cycle by cyto+uorimetric analysis performed on ≥10000 events.
(e values reported are means ± S.D. (푛 = 5). Assessment of cell death showed statistically signi,cant di-erences between the data obtained
in the cultures treated with TN and 4휇8c in comparison with the cultures treated only with TN (∗푃 < 0.0001).
through IRE1훼 activity and that this ER sensor plays a pro-
survival role.
3.6. Hsp70-IRE1훼 Axis Contrasts Apoptosis in ER Stressed
Cells. TN and TG induce apoptosis in U937 cells as above
and previously reported [33]. Here we show that in these
cells PARP-1 was cleaved, indicating caspase 3 activa-
tion (Figure 5(a)). Furthermore, conditions a-ecting Hsp70
expression, that is, the use of Q or speci,c silencing of
Hsp70, increased PARP-1 cleavage, which appeared more
conspicuous a/er cell treatment with TN (Figures 5(a) and
5(b)).
Detection by +ow cytometry of sub-G1 events is con-
sidered to be indicative of apoptosis. An increase of sub-G1
events was observed a/er Hsp70 impairment with Q or a/er
IRE1훼 inhibition with 4휇8c that was prevented by the use of
z-VAD.fmk, a pan-caspase inhibitor (70 휇M, pretreatment for
60min) (Figure 5(c)).
(ese results indicate that either the impairment ofHsp70
expression or the inhibition of IRE1훼 endoribonuclease activ-
ity cause apoptosis of ER stressed U937 cells. Taken together,
these ,ndings suggest that Hsp70-IRE1훼 axis is a kind of hub
around which are regulated survival and apoptosis mech-
anisms.
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Figure 5: Hsp70-IRE1훼 axis protects from apoptosis. (a) Q induces fragmentation of PARP-1. Western blot was performed with anti-PARP-1
followed by peroxidase-conjugated secondary antibody to analyze this protein (FL = full length; CL = cleaved) in the lysates of untreated or
Q (10휇M) pretreated cells and therea/er treated with none or TN for 24 h.Western blot of Hsp90 is shown at the bottom as a loading control.
Representative blots are shown. (b) Western blot analysis of PARP-1 (FL = full length; CL = cleaved) by speci,c antibody in the lysates of
U937 cells transfected with equal amounts of Hsp70 siRNA or scr-siRNA (Santa Cruz) for 72 h and exposed to none or to TN 1 휇M for further
24 h. Western blot analysis of Hsp90 is shown at the bottom, as a loading control and also to con,rm the speci,city of the transfected siRNA.
Representative blots are shown. (c) Detection of cell death by evaluation of sub-G1 events. U937 cells were pretreated for 60min with none or
z-VAD.fmk (70 휇M), then for further 30min with none or Q (10 휇M) or 4휇8c (10 휇M), and therea/er for 24 h with none or TN (1휇M).(e
cells were ,xed and stained with PI to evaluate sub-G1 events in the cell cycle by cyto+uorimetric analysis performed on ≥10000 events.(e
values reported are means ± S.D. (푛 = 5). Assessment of cell death showed statistically signi,cant di-erences between the data obtained in the
cultures treated with TN and Q and z-VAD in comparison with the cultures treated only with TN and Q (∗푃 < 0.0001) or between the data
obtained in the cultures treated with TN and 4휇8c and z-VAD in comparison with the cultures treated only with TN and 4휇8c (∗∗푃 < 0.0001).
4. Discussion
ER stress-activated gene transcription is mediated by three
di-erent but interconnected pathways: PERK-ATF-4, ATF6,
and IRE1훼-XBP-1s.(e transducers of these pathways (PERK,
ATF6, and IRE1훼) sense the presence of unfolded proteins in
the ER lumen and convey this information to the nucleus.
IRE1훼 activation leads to XBP-1 alternative splicing and,
among other proteins, to BiP upregulation involved in cell
survival [9–13]. It is known that the knocking down of IRE1훼
enhances cell death under conditions of chronic ER stress
and that prolonging of IRE1훼 signaling, independently of ER
stress, can promote cell survival [37–39].
A functional crosstalk between Hsp70 and ER stress has
been observed in a number of physiological and pathological
conditions, such as a cellular model of Parkinson’s disease
induced by 6-hydroxy dopamine (6-OHDA) or following
proteasome inhibition [40, 41]. It has also been reported that
the regulation of the UPR is associated with the formation of
a stable complex between Hsp72 and the cytosolic domain of
IRE1훼 and that Hsp72, although having no e-ect on the half-
life of this ER sensor, enhances its RNase activity, suggesting
a direct interaction [20]. Overall, those results have shown
that Hsp72 is a component of the UPRosome that, by binding
IRE1훼, enhances XBP-1 signaling and promotes adaptation to
ER stress and cell survival.
In the present work we set out to explore the relationship
between Hsp70 expressed by U937 leukemia cells and IRE1훼,
in order to test the hypothesis that constitutive Hsp70,
enhancing the amplitude of IRE1훼 signaling, promotes cell
survival under conditions of ER stress. To this end, we used
doses of ER stressors causing a moderate ER stress allowing
the survival of U937 cells and we inhibited Hsp70 expression
by Q or speci,c siRNA.
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(e induction of theHsp in higher organisms is regulated
at the transcriptional and translational levels. (e transcrip-
tion of heat shock genes is regulated by the cis-acting heat
shock element (HSE) in the promoter region and the trans-
acting heat shock factor (HSF). Q action has been examined
on the promoter region of the human Hsp70 gene, especially
on the formation of the HSF-HSE complex a/er activation
either in vivo by heat shock or in vitro by heat treatment,
urea, or Nonidet P-40 [28]. It was detected that Q inhibits
the binding of HSF to the HSE both in vivo and in vitro.
(us, Q interaction with HSF leads to the inhibition of this
transcription factor and of Hsp70 [28]. Our studies have
con,rmed that this +avonoid a-ects Hsp70 expression also
in human U937 cells under basal conditions and upon ER
stress.
Q or speci,c silencing of Hsp70 prevented also the
upregulation of IRE1훼 induced by ER stress, suggesting a
functional link between Hsp70 and IRE1훼, allowing the
increased expression of the latter protein under conditions
of ER stress that could be due to an increased translation of
IRE1훼 or to a physical connection leading to an increased
half-life of IRE1훼. Although we did not explore the link of
Hsp70 to theUPRosome, wewere able to pinpoint that, under
ER stress, the Hsp70-IRE1훼 axis permits the upregulation of
BiP, while it is not a-ecting CHOP in U937 cells. In fact,
the ER stressors induced both BiP and CHOP, while IRE1훼
downregulation prevented only the expression of BiP. How-
ever, the cells survived when both BiP and CHOP expression
increased, while apoptosis was induced a/er inhibition of
the Hsp70-IRE1훼 axis and BiP downregulation. (e same
e-ect on cell survival was obtained also a/er speci,c silencing
of IRE1훼 or inhibition of its endoribonuclease activity with
4휇8c. (us, Hsp70, by regulating IRE1훼 expression, plays a
role in a survival pathway featuring BiP, since this protein
is antiapoptotic and prevents ER stress-induced cell death
[13, 14].
(e accumulation of unfolded proteins following ER
stress, in defect of IRE1훼, is supposed to lead to the activation
of the other two sensors [42]. In this context the concomitant
decrease of BiP may represent a crucial step, as this protein
is an inhibitory chaperone of the three ER sensors. (us,
the possible activation of PERK, via ATF4, may cause the
increased expression of the proapoptotic CHOP. As this
scenario generally occurs in severe ER stress [42, 43], we
hypothesize that the impairment of the Hsp70-IRE1훼 axis
turns a mild ER stress into a severe ER stress, associated with
increased expression of CHOP.
In conclusion, in this study we show that quercetin, a
major dietary +avonoid, downregulates the expression of
Hsp70 in monoblastic leukemia U937 cells. Quercetin or
speci,cHsp70 siRNAprevents the upregulation of IRE1훼 and
BiP, during endoplasmic reticulum stress, induced by TN or
TG. (is condition of ER stress and dysregulation of IRE1훼
and BiP promotes cell death.
(ese results indicate that, during ER stress, Hsp70 and
IRE1훼 represent candidate targets to kill leukemia cells and
that quercetin may be employed at this purpose.
Abbreviations
ATF6: Activating transcription factor 6
BiP: Immunoglobulin heavy-chain
binding protein
BSA: Bovine serum albumin
CHOP: CCAAT/enhancer-binding
protein-homologous protein
ECL: Enhanced chemiluminescence
ER: Endoplasmic reticulum
FCS: Fetal calf serum
GRP78: 78 kDa glucose-regulated protein
HRP: Horseradish peroxidase
Hsp: Heat shock protein
IRE1훼: Inositol-requiring kinase 1훼
PBS: Phosphate bu-ered saline
PERK: Protein kinase RNA- (PKR-) like
ER kinase
PES: 2-Phenylethynesulfonamide
PI: Propidium iodide
PVDF: Polyvinylidene di+uoride
Q: Quercetin
RC-DC protein assay: Reducing agent and detergent
compatible protein assay
SDS-PAGE: Sodium-dodecyl-sulphate-
polyacrylamide gel
electrophoresis
siRNA: Small interfering RNA
TBS: Tris-bu-ered saline
TG: (apsigargin
TN: Tunicamycin
UPR: Unfolded protein response
XBP-1: X-box binding protein 1.
Conflict of Interests
(e authors declare that they have no con+ict of interests
relating to the present study.
Authors’ Contribution
Antonello Storniolo performed most of the experiments,
participated in the study design, and analyzed results. Marisa
Raciti performed several experiments. Alessandra Cucina
and Mariano Bizzarri participated in the study design and
analyzed the results. Livia Di Renzo designed the experi-
ments, analyzed the results, coordinated the study group, and
wrote the paper.
Acknowledgments
(is work was supported by grants to Livia Di Renzo from
Sapienza Ateneo 2011 (8.1.1.1.34.1) and Sapienza Ateneo 2012
(8.1.1.1.38.1).
References
[1] R. J. Kaufman, “Stress signaling from the lumen of the endo-
plasmic reticulum: coordination of gene transcriptional and
10 Oxidative Medicine and Cellular Longevity
translational controls,” Genes & Development, vol. 13, pp. 1211–
1233, 1999.
[2] H. P. Harding, M. Calfon, F. Urano, I. Novoa, and D. Ron,
“Transcriptional and translational control in the mammalian
unfolded protein response,” Annual Review of Cell and Devel-
opmental Biology, vol. 18, pp. 575–599, 2002.
[3] D. Ron and P. Walter, “Signal integration in the endoplasmic
reticulum unfolded protein response,” Nature Reviews Molecu-
lar Cell Biology, vol. 8, no. 7, pp. 519–529, 2007.
[4] E. Szegezdi, S. E. Logue, A. M. Gorman, and A. Samali,
“Mediators of endoplasmic reticulum stress-induced apopto-
sis,” EMBO Reports, vol. 7, no. 9, pp. 880–885, 2006.
[5] C. Xu, B. Bailly-Maitre, and J. C. Reed, “Endoplasmic reticulum
stress: cell life and death decisions,” *e Journal of Clinical
Investigation, vol. 115, no. 10, pp. 2656–2664, 2005.
[6] H. P. Harding, I. Novoa, A. Bertolotti et al., “Translational
regulation in the cellular response to biosynthetic load on
the endoplasmic reticulum,” Cold Spring Harbor Symposia on
Quantitative Biology, vol. 66, pp. 499–508, 2001.
[7] M. Schro¨der and R. J. Kaufman, “(e mammalian unfolded
protein response,” Annual Review of Biochemistry, vol. 74, pp.
739–789, 2005.
[8] F. Urano, A. Bertolotti, and D. Ron, “IRE1 and e-erent signaling
from the endoplasmic reticulum,” Journal of Cell Science, vol.
113, no. 21, pp. 3697–3702, 2000.
[9] A. Bertolotti, Y. Zhang, L.M.Hendershot, H. P. Harding, andD.
Ron, “Dynamic interaction of BiP and ER stress transducers in
the unfolded-protein response,” Nature Cell Biology, vol. 2, no.
6, pp. 326–332, 2000.
[10] Y. Kimata, D. Oikawa, Y. Shimizu, Y. Ishiwata-Kimata, and K.
Kohno, “A role for BiP as an adjustator for the endoplasmic
reticulum stress-sensing IRE1,” Journal of Cell Biology, vol. 167,
no. 3, pp. 445–456, 2004.
[11] K. Lee, W. Tirasophon, X. Shen et al., “IRE1-mediated uncon-
ventional mRNA splicing and S2P-mediated ATF6 cleavage
merge to regulate XBP1 in signaling the unfolded protein
response,” Genes & Development, vol. 16, no. 4, pp. 452–466,
2002.
[12] H. Yoshida, T. Matsui, A. Yamamoto, T. Okada, and K. Mori,
“XBP1 mRNA is induced by ATF6 and spliced by IRE1 in
response to ER stress to produce a highly active transcription
factor,” Cell, vol. 107, no. 7, pp. 881–891, 2001.
[13] Y. Kozutsumi, M. Segal, K. Normington, M.-J. Gething, and J.
Sambrook, “(e presence of malfolded proteins in the endo-
plasmic reticulum signals the induction of glucose-regulated
proteins,” Nature, vol. 332, no. 6163, pp. 462–464, 1988.
[14] D. Dong, M. Ni, J. Li et al., “Critical role of the stress chaperone
GRP78/BiP in tumor proliferation, survival, and tumor angio-
genesis in transgene-induced mammary tumor development,”
Cancer Research, vol. 68, no. 2, pp. 498–505, 2008.
[15] X.-Z. Wang, B. Lawson, J. W. Brewer et al., “Signals from
the stressed endoplasmic reticulum induce C/EBP-homologous
protein (CHOP/GADD153),” Molecular and Cellular Biology,
vol. 16, no. 8, pp. 4273–4280, 1996.
[16] S. J. Marciniak, C. Y. Yun, S. Oyadomari et al., “CHOP induces
death by promoting protein synthesis and oxidation in the
stressed endoplasmic reticulum,”Genes & Development, vol. 18,
no. 24, pp. 3066–3077, 2004.
[17] M. P. Mayer and B. Bukau, “Hsp70 chaperones: cellular func-
tions and molecular mechanism,” Cellular and Molecular Life
Sciences, vol. 62, no. 6, pp. 670–684, 2005.
[18] E. Schmitt, L. Maingret, P. E. Puig et al., “Heat shock protein 70
neutralization exerts potent antitumor e-ects in animal models
of colon cancer and melanoma,” Cancer Research, vol. 66, no. 8,
pp. 4191–4197, 2006.
[19] C. Garrido, E. Schmitt, C. Cande´, N. Vahsen, A. Parcellier,
and G. Kroemer, “HSP27 and HSP70: potentially oncogenic
apoptosis inhibitors.,” Cell cycle, vol. 2, no. 6, pp. 579–584, 2003.
[20] S. Gupta, A. Deepti, S. Deegan, F. Lisbona, C. Hetz, and A.
Samali, “HSP72 protects cells from ER stress-induced apoptosis
via enhancement of IRE1훼-XBP1 signaling through a physical
interaction,” PLoS Biology, vol. 8, no. 7, Article ID e1000410,
2010.
[21] J.-S. Seo, Y.-M. Park, J.-I. Kim et al., “T cell lymphoma in
transgenicmice expressing the humanHsp70 gene,”Biochemical
and Biophysical Research Communications, vol. 218, no. 2, pp.
582–587, 1996.
[22] A. Samali and T. G. Cotter, “Heat shock proteins increase
resistance to apoptosis,”Experimental Cell Research, vol. 223, no.
1, pp. 163–170, 1996.
[23] A. Saleh, S. M. Srinivasula, L. Balkir, P. D. Robbins, and E.
S. Alnemri, “Negative regulation of the Apaf-1 apoptosome by
Hsp70,” Nature Cell Biology, vol. 2, no. 8, pp. 476–483, 2000.
[24] C. Bivik, I. Rosdahl, and K. O¨llinger, “Hsp70 protects against
UVB induced apoptosis by preventing release of cathepsins and
cytochrome c in human melanocytes,” Carcinogenesis, vol. 28,
no. 3, pp. 537–544, 2007.
[25] L. Ravagnan, S. Gurbuxani, S. A. Susin et al., “Heat-shock
protein 70 antagonizes apoptosis-inducing factor,” Nature Cell
Biology, vol. 3, no. 9, pp. 839–843, 2001.
[26] P. J. Muchowski and J. L. Wacker, “Modulation of neurodegen-
eration bymolecular chaperones,”Nature ReviewsNeuroscience,
vol. 6, no. 1, pp. 11–22, 2005.
[27] R. I. Morimoto, “Proteotoxic stress and inducible chaperone
networks in neurodegenerative disease and aging,” Genes &
Development, vol. 22, no. 11, pp. 1427–1438, 2008.
[28] N. Hosokawa, K. Hirayoshi, H. Kudo et al., “Inhibition of
the activation of heat shock factor in vivo and in vitro by
+avonoids,” Molecular and Cellular Biology, vol. 12, no. 8, pp.
3490–3498, 1992.
[29] D. R. Ferry, A. Smith, J.Malkhandi et al., “Phase I clinical trial of
the +avonoid quercetin: pharmacokinetics and evidence for in
vivo tyrosine kinase inhibition,”Clinical Cancer Research, vol. 2,
no. 4, pp. 659–668, 1996.
[30] I. Nicoletti, G. Migliorati, M. C. Pagliacci, F. Grignani, and C.
Riccardi, “A rapid and simple method for measuring thymocyte
apoptosis by propidium iodide staining and +ow cytometry,”
Journal of Immunological Methods, vol. 139, no. 2, pp. 271–279,
1991.
[31] G. Matusali, G. Arena, A. De Leo, L. Di Renzo, and E. Mattia,
“Inhibition of p38MAP kinase pathway induces apoptosis and
prevents Epstein Barr virus reactivation in Raji cells exposed
to lytic cycle inducing compounds,” Molecular Cancer, vol. 8,
article 18, 2009.
[32] G. Marfe`, E. Morgante, C. Di Stefano et al., “Sorbitol-induced
apoptosis of human leukemia is mediated by caspase activation
and cytochrome c release,” Archives of Toxicology, vol. 82, no. 6,
pp. 371–377, 2008.
[33] M. Raciti, L. V. Lotti, S. Valia, F. M. Pulcinelli, and L. Di Renzo,
“JNK2 is activated during ER stress and promotes cell survival,”
Cell Death & Disease, vol. 3, article e429, 2012.
Oxidative Medicine and Cellular Longevity 11
[34] J. I.-J. Leu, J. Pimkina, A. Frank,M. E.Murphy, andD. L.George,
“A small molecule inhibitor of inducible heat shock protein 70,”
Molecular Cell, vol. 36, no. 1, pp. 15–27, 2009.
[35] M. Granato, V. Lacconi, M. Peddis et al., “HSP70 inhibition
by 2-phenylethynesulfonamide induces lysosomal cathepsin
D release and immunogenic cell death in primary e-usion
lymphoma,”Cell Death&Disease, vol. 4, no. 7, article e730, 2013.
[36] B. C. Cross, P. J. Bond, P. G. Sadowski et al., “(e molecular
basis for selective inhibition of unconventional mRNA splicing
by an IRE1-binding small molecule,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 109, no.
15, pp. E869–E878, 2012.
[37] F. Lisbona, D. Rojas-Rivera, P. (ielen et al., “BAX inhibitor-1
is a negative regulator of the ER stress sensor IRE1훼,”Molecular
Cell, vol. 33, no. 6, pp. 679–691, 2009.
[38] D. Han, A. G. Lerner, L. V. Walle et al., “IRE1훼 kinase activation
modes control alternate endoribonuclease outputs to determine
divergent cell fates,” Cell, vol. 138, no. 3, pp. 562–575, 2009.
[39] J. H. Lin, H. Li, D. Yasumura et al., “IRE1 signaling a-ects cell
fate during the unfolded protein response,” Science, vol. 318, no.
5852, pp. 944–949, 2007.
[40] E. J. Ryu, H. P. Harding, J. M. Angelastro, O. V. Vitolo, D.
Ron, and L. A. Greene, “Endoplasmic reticulum stress and the
unfolded protein response in cellular models of Parkinson’s
disease,” Journal of Neuroscience, vol. 22, no. 24, pp. 10690–
10698, 2002.
[41] A. Szokalska, M. Makowski, D. Nowis et al., “Proteasome inhi-
bition potentiates antitumor e-ects of photodynamic therapy
in mice through induction of endoplasmic reticulum stress and
unfolded protein response,” Cancer Research, vol. 69, no. 10, pp.
4235–4243, 2009.
[42] C. Hetz, “(e unfolded protein response: controlling cell fate
decisions under ER stress and beyond,” Nature Reviews Molec-
ular Cell Biology, vol. 13, no. 2, pp. 89–102, 2012.
[43] D. T. Rutkowski, S. M. Arnold, C. N. Miller et al., “Adaptation
to ER stress is mediated by di-erential stabilities of pro-survival
and pro-apoptotic mRNAs and proteins,” PLoS Biology, vol. 4,
no. 11, article e374, 2006.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 201?
Hindawi Publishing Corporation
http://www.hindawi.com Volume 201?
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 201?
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 201?
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
??????????????
?????????????
???????????????????????????????
?????????????????????? ???????????
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 201?
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 201?
Hindawi Publishing Corporation
http://www.hindawi.com Volume 201?
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 201?
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 201?
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 201?
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 201?
Hindawi Publishing Corporation
http://www.hindawi.com
